236 related articles for article (PubMed ID: 37672319)
1. Elevated CDKN1A (P21) mediates β-thalassemia erythroid apoptosis, but its loss does not improve β-thalassemic erythropoiesis.
Liang R; Lin M; Menon V; Qiu J; Menon A; Breda L; Arif T; Rivella S; Ghaffari S
Blood Adv; 2023 Nov; 7(22):6873-6885. PubMed ID: 37672319
[TBL] [Abstract][Full Text] [Related]
2. Effect of Tumor Necrosis Factor-Alpha on Erythropoietin and Erythropoietin Receptor-Induced Erythroid Progenitor Cell Proliferation in β-Thalassemia/Hemoglobin E Patients.
Tanyong DI; Panichob P; Kheansaard W; Fucharoen S
Turk J Haematol; 2015 Dec; 32(4):304-10. PubMed ID: 26376749
[TBL] [Abstract][Full Text] [Related]
3. The pyruvate kinase activator mitapivat reduces hemolysis and improves anemia in a β-thalassemia mouse model.
Matte A; Federti E; Kung C; Kosinski PA; Narayanaswamy R; Russo R; Federico G; Carlomagno F; Desbats MA; Salviati L; Leboeuf C; Valenti MT; Turrini F; Janin A; Yu S; Beneduce E; Ronseaux S; Iatcenko I; Dang L; Ganz T; Jung CL; Iolascon A; Brugnara C; De Franceschi L
J Clin Invest; 2021 May; 131(10):. PubMed ID: 33822774
[TBL] [Abstract][Full Text] [Related]
4. FOXO3-mTOR metabolic cooperation in the regulation of erythroid cell maturation and homeostasis.
Zhang X; Campreciós G; Rimmelé P; Liang R; Yalcin S; Mungamuri SK; Barminko J; D'Escamard V; Baron MH; Brugnara C; Papatsenko D; Rivella S; Ghaffari S
Am J Hematol; 2014 Oct; 89(10):954-63. PubMed ID: 24966026
[TBL] [Abstract][Full Text] [Related]
5. A human anti-matriptase-2 antibody limits iron overload, α-globin aggregates, and splenomegaly in β-thalassemic mice.
Wake M; Palin A; Belot A; Berger M; Lorgouilloux M; Bichon M; Papworth J; Bayliss L; Grimshaw B; Rynkiewicz N; Paterson J; Poindron A; Spearing E; Carter E; Hudson R; Campbell M; Petzer V; Besson-Fournier C; Latour C; Largounez A; Gourbeyre O; Fay A; Coppin H; Roth MP; Theurl I; Germaschewski V; Meynard D
Blood Adv; 2024 Apr; 8(8):1898-1907. PubMed ID: 38241484
[TBL] [Abstract][Full Text] [Related]
6. Ferroportin inhibitor vamifeport ameliorates ineffective erythropoiesis in a mouse model of β-thalassemia with blood transfusions.
Kalleda N; Flace A; Altermatt P; Ingoglia G; Doucerain C; Nyffenegger N; Dürrenberger F; Manolova V
Haematologica; 2023 Oct; 108(10):2703-2714. PubMed ID: 37165842
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol accelerates erythroid maturation by activation of FoxO3 and ameliorates anemia in beta-thalassemic mice.
Franco SS; De Falco L; Ghaffari S; Brugnara C; Sinclair DA; Matte' A; Iolascon A; Mohandas N; Bertoldi M; An X; Siciliano A; Rimmelé P; Cappellini MD; Michan S; Zoratti E; Anne J; De Franceschi L
Haematologica; 2014 Feb; 99(2):267-75. PubMed ID: 23975182
[TBL] [Abstract][Full Text] [Related]
8. Pleckstrin-2 is essential for erythropoiesis in β-thalassemic mice, reducing apoptosis and enhancing enucleation.
Feola M; Zamperone A; Moskop D; Chen H; Casu C; Lama D; Di Martino J; Djedaini M; Papa L; Martinez MR; Choesang T; Bravo-Cordero JJ; MacKay M; Zumbo P; Brinkman N; Abrams CS; Rivella S; Hattangadi S; Mason CE; Hoffman R; Ji P; Follenzi A; Ginzburg YZ
Commun Biol; 2021 May; 4(1):517. PubMed ID: 33941818
[TBL] [Abstract][Full Text] [Related]
9. Association of the Degree of Erythroid Expansion and Maturation Arrest with the Clinical Severity of β0-Thalassemia/Hemoglobin E Patients.
Suriyun T; Kaewsakulthong W; Khamphikham P; Chumchuen S; Hongeng S; Fucharoen S; Sripichai O
Acta Haematol; 2021; 144(6):660-671. PubMed ID: 34535581
[TBL] [Abstract][Full Text] [Related]
10. Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine β-thalassemia.
Suragani RN; Cawley SM; Li R; Wallner S; Alexander MJ; Mulivor AW; Gardenghi S; Rivella S; Grinberg AV; Pearsall RS; Kumar R
Blood; 2014 Jun; 123(25):3864-72. PubMed ID: 24795345
[TBL] [Abstract][Full Text] [Related]
11. betaMinor-globin messenger RNA accumulation in reticulocytes governs improved erythropoiesis in beta thalassemic mice after erythropoietin complementary DNA electrotransfer in muscles.
Samakoglu S; Fattori E; Lamartina S; Toniatti C; Stockholm D; Heard JM; Bohl D
Blood; 2001 Apr; 97(8):2213-20. PubMed ID: 11290581
[TBL] [Abstract][Full Text] [Related]
12. Improvement of erythropoiesis in beta-thalassemic mice by continuous erythropoietin delivery from muscle.
Bohl D; Bosch A; Cardona A; Salvetti A; Heard JM
Blood; 2000 May; 95(9):2793-8. PubMed ID: 10779423
[TBL] [Abstract][Full Text] [Related]
13. Exogenous iron increases hemoglobin in beta-thalassemic mice.
Ginzburg YZ; Rybicki AC; Suzuka SM; Hall CB; Breuer W; Cabantchik ZI; Bouhassira EE; Fabry ME; Nagel RL
Exp Hematol; 2009 Feb; 37(2):172-83. PubMed ID: 19059700
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of thalassemia.
Schrier SL
Curr Opin Hematol; 2002 Mar; 9(2):123-6. PubMed ID: 11844995
[TBL] [Abstract][Full Text] [Related]
15. Differential regulatory and compensatory responses in hematopoiesis/erythropoiesis in alpha- and beta-globin hemizygous mice.
Beauchemin H; Blouin MJ; Trudel M
J Biol Chem; 2004 May; 279(19):19471-80. PubMed ID: 15004025
[TBL] [Abstract][Full Text] [Related]
16. Erythroferrone exacerbates iron overload and ineffective extramedullary erythropoiesis in a mouse model of β-thalassemia.
Olivera J; Zhang V; Nemeth E; Ganz T
Blood Adv; 2023 Jul; 7(14):3339-3349. PubMed ID: 36995275
[TBL] [Abstract][Full Text] [Related]
17. The Interplay Between Peroxiredoxin-2 and Nuclear Factor-Erythroid 2 Is Important in Limiting Oxidative Mediated Dysfunction in β-Thalassemic Erythropoiesis.
Matte A; De Falco L; Iolascon A; Mohandas N; An X; Siciliano A; Leboeuf C; Janin A; Bruno M; Choi SY; Kim DW; De Franceschi L
Antioxid Redox Signal; 2015 Dec; 23(16):1284-97. PubMed ID: 26058667
[TBL] [Abstract][Full Text] [Related]
18. Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in beta-thalassemia.
Libani IV; Guy EC; Melchiori L; Schiro R; Ramos P; Breda L; Scholzen T; Chadburn A; Liu Y; Kernbach M; Baron-Lühr B; Porotto M; de Sousa M; Rachmilewitz EA; Hood JD; Cappellini MD; Giardina PJ; Grady RW; Gerdes J; Rivella S
Blood; 2008 Aug; 112(3):875-85. PubMed ID: 18480424
[TBL] [Abstract][Full Text] [Related]
19. Correcting β-thalassemia by combined therapies that restrict iron and modulate erythropoietin activity.
Casu C; Pettinato M; Liu A; Aghajan M; Lo Presti V; Lidonnici MR; Munoz KA; O'Hara E; Olivari V; Di Modica SM; Booten S; Guo S; Neil G; Miari R; Shapir N; Zafir-Lavie I; Domev H; Ferrari G; Sitara D; Nai A; Rivella S
Blood; 2020 Oct; 136(17):1968-1979. PubMed ID: 32556142
[TBL] [Abstract][Full Text] [Related]
20. Ineffective erythropoiesis in β -thalassemia.
Ribeil JA; Arlet JB; Dussiot M; Moura IC; Courtois G; Hermine O
ScientificWorldJournal; 2013; 2013():394295. PubMed ID: 23606813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
